111 filings
Page 3 of 6
424B3
FRPRQ
4D Pharma PLC
10 Jan 22
Prospectus supplement
3:34pm
424B3
FRPRQ
4D Pharma PLC
10 Jan 22
Prospectus supplement
3:31pm
6-K
FRPRQ
4D Pharma PLC
5 Jan 22
Current report (foreign)
3:56pm
6-K
FRPRQ
4D Pharma PLC
14 Dec 21
4D pharma announces positive topline results from Part A of Phase I/II trial of MRx-4DP0004 for the treatment of asthma
11:22am
EFFECT
FRPRQ
4D Pharma PLC
15 Oct 21
Notice of effectiveness
12:15am
424B3
FRPRQ
4D Pharma PLC
14 Oct 21
Prospectus supplement
4:51pm
CORRESP
FRPRQ
4D Pharma PLC
12 Oct 21
Correspondence with SEC
12:00am
F-1/A
FRPRQ
4D Pharma PLC
7 Oct 21
Registration statement (foreign) (amended)
12:00am
EFFECT
FRPRQ
4D Pharma PLC
4 Oct 21
Notice of effectiveness
12:15am
POS AM
FRPRQ
4D Pharma PLC
1 Oct 21
Prospectus update (post-effective amendment)
12:00am
424B3
FRPRQ
4D Pharma PLC
30 Sep 21
Prospectus supplement
9:55pm
6-K
FRPRQ
4D Pharma PLC
30 Sep 21
Current report (foreign)
9:54pm
6-K
FRPRQ
4D Pharma PLC
30 Sep 21
Interim results for the six months ended 30 June 2021
6:10am
6-K
FRPRQ
4D Pharma PLC
23 Sep 21
4D pharma presents two clinical posters for Live Biotherapeutic MRx0518 at the European Society for Medical Oncology (ESMO) Congress 2021
4:53pm
UPLOAD
FRPRQ
4D Pharma PLC
21 Sep 21
Letter from SEC
12:00am
F-1
FRPRQ
4D Pharma PLC
14 Sep 21
Registration statement (foreign)
12:00am
424B3
FRPRQ
4D Pharma PLC
11 Aug 21
Prospectus supplement
3:17pm
6-K
FRPRQ
4D Pharma PLC
2 Aug 21
4D pharma Announces $30 Million Credit Facility with Oxford Finance
11:20am
424B3
FRPRQ
4D Pharma PLC
27 Jul 21
Prospectus supplement
4:32pm
6-K
FRPRQ
4D Pharma PLC
27 Jul 21
4D pharma Announces Passing of Chief Financial Officer John Beck
4:32pm